EP2708223A1 - Agent de coloration et son utilisation - Google Patents

Agent de coloration et son utilisation Download PDF

Info

Publication number
EP2708223A1
EP2708223A1 EP12782916.6A EP12782916A EP2708223A1 EP 2708223 A1 EP2708223 A1 EP 2708223A1 EP 12782916 A EP12782916 A EP 12782916A EP 2708223 A1 EP2708223 A1 EP 2708223A1
Authority
EP
European Patent Office
Prior art keywords
dyeing
condition
enzyme
modified
dyeing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP12782916.6A
Other languages
German (de)
English (en)
Other versions
EP2708223A4 (fr
EP2708223B1 (fr
Inventor
Yoshihiko Hirose
Yukihide Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amano Enzyme Inc
Original Assignee
Amano Enzyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amano Enzyme Inc filed Critical Amano Enzyme Inc
Publication of EP2708223A1 publication Critical patent/EP2708223A1/fr
Publication of EP2708223A4 publication Critical patent/EP2708223A4/fr
Application granted granted Critical
Publication of EP2708223B1 publication Critical patent/EP2708223B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/32—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using oxidation dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0061—Laccase (1.10.3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0063—Ascorbate oxidase (1.10.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/03—Oxidoreductases acting on the CH-CH group of donors (1.3) with oxygen as acceptor (1.3.3)
    • C12Y103/03005—Bilirubin oxidase (1.3.3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
    • C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
    • C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
    • C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
    • C12Y110/03002—Laccase (1.10.3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
    • C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
    • C12Y110/03003—L-ascorbate oxidase (1.10.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
    • C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
    • C12Y110/03004—O-aminophenol oxidase (1.10.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
    • C12Y114/18001—Tyrosinase (1.14.18.1)
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P3/00—Special processes of dyeing or printing textiles, or dyeing leather, furs, or solid macromolecular substances in any form, classified according to the material treated
    • D06P3/02—Material containing basic nitrogen
    • D06P3/04—Material containing basic nitrogen containing amide groups
    • D06P3/14—Wool

Definitions

  • the present invention relates to a dyeing agent and use thereof. Specifically, the present invention relates to a dyeing agent and a process for dyeing using a modified oxidase.
  • the present application claims priority based on Japanese Patent Application No. 2011-106532 filed on May 11, 2011 , priority based on Japanese Patent Application No. 2011-154209 filed on July 12, 2011 and priority based on Japanese Patent Application No. 2011-263158 filed on December 1, 2011 , and all of the contents of these patent applications are incorporated by reference.
  • Dyeing processes utilizing oxidation dye such as phenylenediamines and aminophenols are frequently used in dyeing of keratin fibers, specifically human hairs and the like, by utilizing the advantages that dyeing in various color tones is possible and the duration is long, as well as that the dyeing time is short, and the like.
  • Hydrogen peroxide has been conventionally used for the color development of oxidation dyes.
  • hydrogen peroxide has a strong irritant property, and hairs and scalps and the like are damaged by using hydrogen peroxide.
  • use of an oxidase instead of hydrogen peroxide has been attempted (for example, see Patent Documents 1 to 3).
  • the object of the present invention is to provide a process for dyeing that can provide an excellent dyeing effect when utilizing an oxidase, and a dyeing agent for use in the process.
  • the present inventors researched by using bilirubin oxidase, which is one of oxidases, under the conception that the affinity of an enzyme for a material is especially important in a process for dyeing using an oxidase.
  • the inventors did many studies aiming at improving the dyeing effect, for example, in the dyeing of human hairs, and consequently showed that the dyeing effect is dramatically increased by using bilirubin oxidase to which positive charge has been added by a chemical modification with an amine (referred to as modified BO or PMO). Furthermore, they also observed a fine dyeing property also at a relatively low pH. Furthermore, it was clarified that dyeing by modified BO is excellent in shampoo resistance.
  • a modified enzyme enhances the dyeing effect also in the case when an indole compound, which is considered to be safer, is used as a chromogenic substrate. Furthermore, the dyeing by the modified enzyme was excellent in shampoo resistance. Furthermore, it was confirmed that a color (color tone) in dyeing can be adjusted by using two or more kinds of indole compounds in combination.
  • the first aspect of the present invention relates to a dyeing agent used for dyeing fibers or processed fibers.
  • the dyeing agent of the present invention is used for the dyeing of, for example, fibers, yarns, fabrics, woven fabrics or clothes or the like formed of keratin, cotton, diacetate, flax, linen, lyocell, polyacrylics, polyamides, polyesters, ramie, rayon, Tencel (registered trademark) or triacetate.
  • the dyeing agent of the present invention contains an oxidase that has undergone a predetermined modification (hereinafter referred to as "modified enzyme").
  • modified enzyme oxidase that has undergone a predetermined modification
  • the dyeing agent of the present invention acts on an oxidation dye to exert a desired dyeing effect.
  • the dyeing agent of the present invention is typically used in combination with an oxidation dye.
  • the expression “used in combination” or “formed by combining with” refers to that the oxidation dye and the modified enzyme are used in combination.
  • the dyeing agent of the present invention is provided as a composition in which the oxidation dye and the modified enzyme are mixed.
  • the dyeing agent of the embodiment is referred to as a one-component type dyeing agent.
  • the dyeing agent of the embodiment is referred to as a two-component type dyeing agent.
  • the respective elements are provided in the state that they are housed in separated containers or compartments, and the two elements are mixed upon use. Meanwhile, it can be considered that the one-component type dyeing agent is superior to the two-component type dyeing agent in that it has a simple constitution and can attain an easier process of use.
  • oxidation dye refers to a dye that requires an oxidation reaction for color development or dyeing.
  • the oxidation dye includes "a dye precursor” that develops a color by the oxidative polymerization of the precursor itself, and "a dye aid (coupler)” that exhibits an inherent color tone by being polymerized with a dye precursor.
  • a suitable oxidation dye is adopted depending on the intended use of the dyeing agent of the present invention.
  • oxidation dye examples include acridine, anthracene, azulene, benbene, benzofuran, benzothiazole, benzothiazoline, carboline, carbazole, cinnoline, chromane, chromene, chrysene, fulvene, furan, imidazole, indazole, indene, indole, indoline, indolizine, isothiazole, isoquinoline, isoxazole, naphthalene, naphthylene, naphthylpyridine, oxazole, perylene, phenanthrene, phenazine, phthalazine, pteridin, purine, pyran, pyrazole, pyrene, pyridazine, pyridazone, pyridine, pyrimidine, pyrrole, quinazoline, quinoline, quinoxaline, sulfonyl,
  • Aromatic compounds selected from phenylenediamine, aminophenol, cresol, phenol, naphthol, indole or indoline, or derivatives thereof are preferable.
  • the derivatives used herein are those substituted by one or plural functional group(s) or substituent(s).
  • the functional group(s) or substituent(s) that may be introduced herein are selected from the group consisting of halogens; sulfo; sulfonato; sulfamino; sulfanyl; amino; amide; nitro; azo; imino; carboxy; cyano; formyl; hydroxy; halocarbonyl; carbamoyl; carbamidoyl; phosphonato; phosphonyl; C1-18 alkyls; C1-18 alkenyls; C1-18 alkynyls; C1-18 alkoxys; C1-18 oxycarbonyls; C1-18 oxoalkyls; C1-18 alkylsulfanyls; C1-18 alkylsulfonyls; C1-18 alkyliminos or amino, and the respective C1-18 alkyls, C1-18 alkenyls and C1-18 alkynyl groups may be mono-, di- or poly
  • the dyeing agent of the present invention is specifically useful for the dyeing of keratin fibers (human hairs, hairs of cows, horses, sheep, goats, alpacas, Angora rabbits and the like, etc.).
  • the oxidation dye that is preferable for constituting the dyeing agent of the present invention for dyeing keratin fibers include paraphenylenediamines, metaphenylenediamines, orthophenylenediamines, paraaminophenols, metaaminophenols, orthoaminophenols, pyridine derivatives, pyrimidine derivatives, pyrazole derivatives, metadiphenols, naphthols, indoline derivatives, indole derivatives and acid addition salts thereof (as the acid addition salts, for example, hydrochlorides, hydrobromides, sulfates, tartrates, lactates or acetates, and the like may be used.), indoline compounds, and indole compounds.
  • oxidation dyes are paraphenylenediamine, 5-aminoorthocresol, orthoaminophenol, metaaminophenol, paraaminophenol, 2,6-diaminopyridine, 5-(2-hydroxyethylamino)-2-toluenediamine, N,N-bis( ⁇ -hydroxy)-paraphenylenediamine sulfate, paranitro-orthophenylenediamine, paranitro-2',4'-diaminoazobenzene sodium sulfate, toluene-2,5-diamine, 5-aminoorthocresol sulfate, paraaminophenol sulfate, orthochloro-paraphenylenediamine sulfate, 4,4'-diaminodiphenylamine sulfate, paramethylaminophenol sulfate, paraphenylenediamine sulfate, metaphenylenediamine sulfate, tol
  • One or two or more kinds of oxidation dye(s) is/are used for the dyeing agent of the present invention.
  • Combination use of two or more kinds of oxidation dyes is effective for improving the dyeing effect, adjusting the color (color tone), and the like.
  • the contained amount of the oxidation dye is not specifically limited, and the incorporation amount may be determined with consideration for the characteristic of the oxidation dye used, the intended use, and the like.
  • the oxidation dye can be incorporated so as to be, for example, 0.01 to 20% by weight, preferably 0.05 to 10% by weight, further preferably 0.01 to 1% by weight, with respect to the whole amount of the dyeing agent.
  • the oxidation dye can be incorporated so as to be, for example, 0.01 to 20% by weight, preferably 0.05 to 10% by weight, further preferably 0.01 to 1% by weight, with respect to the whole amount of the first element in which the oxidation dye is to be contained.
  • a direct dye may be incorporated in addition to the oxidation dye.
  • the direct dye include 2-amino-4-nitrophenol, 2-amino-5-nitrophenol, 1-amino-4-methylaminoanthraquinone, nitro-p-phenylenediamine hydrochloride, 1,4-diaminoanthraquinone, nitro-p-phenylenediamine, picramic acid, sodium picramate, 2-amino-5-nitrophenol sulfate, resorcinol, nitro-p-phenylenediamine sulfate, p-nitro-o-phenylenediamine sulfate, p-nitro-m-phenylenediamine sulfate, Natural Orange 6 (2-hydroxy-1,4-naphthoquinone), Acid Orange 8, Acid Violet 17, Remazol
  • the contained amount of the direct dye is also not specifically limited.
  • the direct dye can be incorporated so as to be, for example, 0.01 to 20% by weight with respect to the whole amount of the dyeing agent.
  • the direct dye is incorporated in the first element in which the oxidation dye is to be contained and/or the second element in which the modified enzyme is to be contained.
  • the contained amount in this case is, for example, 0.01 to 20% by weight with respect to the whole amount of the first element, and for example, 0.01 to 20% by weight with respect to the whole amount of the second element.
  • two or more kinds of direct dyes can be used in combination as is the case with the oxidation dyes.
  • an oxidase in which the positive charge possessed by the enzyme has been increased more as compared to a natural state (native) is used.
  • an oxidase that has been modified so that positive charge is added is used.
  • catechol oxidase EC 1.10.3.1
  • laccase EC 1.10.3.2
  • bilirubin oxidase EC1.3.3.5
  • o-aminophenol oxidase EC 1.10.3.4
  • ascorbic acid oxidase EC 1.10.3.3
  • monophenol oxidase EC 1.14.18.1
  • Enzymes derived from plants for example, derived from Anacardiacea, derived from Magnifera indica, derived from Schinusmolle, derived from Pleiogynium timoriense, derived from Podocarpacea
  • enzymes derived from animals or enzymes derived from bacteria or fungi (for example, derived from Aspergillus, derived from Botrytis, derived from Collybia, derived from Fomes, derived from Lentinus, derived from Myceliophthora, derived from Neurospora, derived from Pleurotus, derived from Podospora, derived from Scytalidium, derived from Trametes, derived from Rhizoctonia, derived from H. thermoidea, and derived from H. brevispora) can be used.
  • an enzyme produced by a gene recombination technique may be used.
  • bilirubin oxidase is adopted as the oxidase.
  • the bilirubin oxidase for example, those derived from microorganisms belonging to Myrothecium, Coprinus, Penicillium and Bacillus can be used.
  • Myrothecium bacteria may include stock strains of Myrothecium verrucaria MT-1, FERM-BP 653 (see Agricultural and Biological Chemistry, Vol. 45, pp.
  • Myrothecium verrucaria IFO 6113 Myrothecium verrucaria IFO 6133, Myrothecium verrucaria IFO 6351, Myrothecium verrucaria IFO 9056, Myrothecium cinctum IFO 9950, Myrothecium roridum IFO 9531 and the like.
  • Coprinus bacteria may include stock strains of Coprinus cinereus IFO 8371, Coprinus lagopides IFO 30120 and the like.
  • Penicillium bacteria may include Penicillium janthinellum (See Japanese Unexamined Patent Application Publication No. 63-309187 ) and the like.
  • Bacillus bacteria may include Bacillus licheniformis (see Japanese Unexamined Patent Application Publication No. 61-209587 ).
  • a purified preparation of an enzyme bilirubin oxidase can be obtained by liquid-culturing or solid-culturing these strains by a conventional method, and conducting extraction, salting-out, dialysis, ion exchange, gel permeation or the like from the culture liquid.
  • bilirubin oxidases derived from Schizophyllum commune See Japanese Unexamined Patent Application Publication No. 59-135886 ), derived from Asteraceae plants (see Japanese Unexamined Patent Application Publication No.
  • bilirubin oxidases are also known, and these bilirubin oxidases can also be used. Furthermore, bilirubin oxidases are also commercially available (from Amano Enzyme Inc., Takara Bio Inc., Asahi Kasei Corporation, Sigma-Aldrich Corporation and the like), and such commercial products may also be used.
  • Positive charge has been added to the enzyme used in the present invention by a chemical modification using an amine (a diamine or a polyamine (a triamine, a tetraamine or the like) (hereinafter an enzyme that has undergone such modification is referred to as "modified enzyme").
  • modified enzyme an enzyme that has undergone such modification
  • the positive charge has been increased by the addition of an amino group.
  • the means for such modification itself is well-known, and for example, Methods for Chemical Modification of Proteins, ⁇ Vol. 1> and ⁇ Vol. 2> (Gakkai Shuppan Center, Ohno et al.), Protein Hybrids (Kyoritsu Shuppan, edited by Inada) and the like may be referred to.
  • Examples of the amines that can be utilized in the chemical modification include n-butylamine, ethylenedimine, putrescine, 3,3'-diaminodipropylamine, agmatine, N,N'-bis(3-aminopropyl)-1,4-butanediamine, bis(hexamethylene)triamine, 1,5-diaminopentane, diethylenetriamine, spermine, sperdine, or salts thereof, and the like.
  • amino acid residues constituting the enzyme may be substituted by neutral amino acid(s) (for example, glutamine, asparagine, serine) or basic amino acid(s) (for example, arginine, histidine, lysine) by using a gene-engineered means.
  • neutral amino acid(s) for example, glutamine, asparagine, serine
  • basic amino acid(s) for example, arginine, histidine, lysine
  • the substitution of the amino residue(s) as mentioned above is preferably conducted on two or more amino acid residues.
  • the number of the substituted amino acid residues is too much, the enzymatic activity may be affected; therefore, it is preferable to substitute, for example, about 2 to 10 amino acid residues, depending on the enzyme to be modified.
  • the amino acid residues to be substituted may be selected and specified based on whether the enzymatic activity is affected or not as an indication. Namely, it is preferable to conduct substitution after specifying the amino acid residues that do not affect the enzymatic activity (or are unlikely to affect) by utilizing a result of a steric structure analysis and the like. On the other hand, it is preferable to target the amino acid residues positioned on the surface in the steric structure for the substitution.
  • Whether the intended modification has been achieved or not may be judged by, for example, comparing isoelectric points (pI) between the enzyme after the modification and the enzyme before the modification (typically a native enzyme). Namely, if the enzyme after the modification has a higher isoelectric point than that of the enzyme before the modification as a result of the comparison of the isoelectric points by isoelectric focusing or the like, it can be judged that the desired modification (addition of positive charge) has been conducted. On the other hand, in the case when amino groups are added, the presence or absence and degree, and the like of the modification can be judged by quantifying the amino groups.
  • pI isoelectric points
  • the "other modification” as used herein may include chemical modifications by water-soluble polymer substances (polyalkylene glycols, polyvinyl alcohols, polysaccharides, partially hydrolyzed or partially half-esterified copolymers of styrene and maleic anhydride, partially hydrolyzed or partially half-esterified copolymers of divinyl ether and maleic anhydride, partially hydrolyzed or partially half-esterified copolymers of acrylic acid and maleic anhydride, Ficoll, polyamino acids, albumin and the like) (Japanese Unexamined Patent Application Publication No.
  • the dyeing agent of the present invention may contain additional components (optional components) besides the above-mentioned respective components.
  • additional components such as alkaline compounds, picramic acid, sodium sulfite and N-acetyl-L-cysteine, surfactants, oil-based components, silicones, thickening agents, solvents, water, chelating agents, amino acids, various salts, moisturizing agents, antiseptic agents, UV inhibitors, alcohols, polyhydric alcohols, perfume materials and the like can be exemplified.
  • the dyeing agent of the present invention is constituted for dyeing of keratin fibers
  • the dyeing agent containing the alkaline compound when the dyeing agent is applied, the swelling of the keratin fibers is promoted, and thus the dyeing effect is improved.
  • the incorporation amount of the alkaline compound is preset so that a desired pH (for example, pH 7.0-10.0) can be attained upon use.
  • An example of the incorporation amount of the one-component type dyeing agent is 0.01 to 20% by weight with respect to the whole amount of the dyeing agent.
  • the alkaline compound is incorporated in the first element in which the oxidation dye is to be incorporated, and the incorporation amount is, for example, 0.01 to 20% by weight with respect to the whole amount of the first element (however, the alkaline compound may be incorporated in the second element instead of the first element, or the alkaline compound may be incorporated in both of the first element and second element).
  • alkaline compound may include amine compounds such as monoethanolamine, monoisopropanolamine, triethanolamine and diethanolamine, inorganic compounds such as ammonia, sodium hydroxide, potassium hydroxide, ammonium carbonate, sodium carbonate, sodium hydrogen carbonate, potassium carbonate and potassium hydrogen carbonate, and the like.
  • amine compounds such as monoethanolamine, monoisopropanolamine, triethanolamine and diethanolamine
  • inorganic compounds such as ammonia, sodium hydroxide, potassium hydroxide, ammonium carbonate, sodium carbonate, sodium hydrogen carbonate, potassium carbonate and potassium hydrogen carbonate, and the like.
  • the dyeing agent of the present invention is prepared into forms such as a paste (cream) form, an aerosol form, a gel form, a liquid form and a mousse form.
  • a paste (cream) form an aerosol form, a gel form, a liquid form and a mousse form.
  • the forms of the first element and second element are not necessarily the same.
  • the second aspect of the present invention relates to a dyeing process using the dyeing agent of the present invention.
  • fibers or processed fibers they are collectively referred to as "material to be dyed" are treated with the dyeing agent of the present invention under a condition in which oxygen is present (namely, under an oxygen atmosphere).
  • the dyeing agent is diluted as necessary, and thereafter applied to a material to be dyed.
  • the material to be dyed is immersed in a solution in which the dyeing agent is dissolved.
  • the first element and second element are mixed (where necessary, they may be diluted or dissolved in a solvent), and thereafter applied to the material to be dyed.
  • One element (the first element or second element) may be applied on the material to be dyed and then the other element may be applied on the material to be dyed so that the both elements are mixed on the surface and the like of the material to be dyed.
  • the material to be dyed may be immersed in a solution in which the first element and second element are dissolved.
  • the contacting state is maintained for a time required for desired dyeing. At this time, it is also possible to retain the temperature or to warm for enhancing the dyeing effect or for rapid or efficient dyeing.
  • the material to be dyed is human hairs, i.e., for example, in the case when the human hairs are dyed by the dyeing process of the present invention
  • the contacting state is maintained for about 10 minutes to 2 hours, preferably for about 20 minutes to 1 hour.
  • the pH condition during the treatment depends on the dyeing agent used. However, it is also possible to adjust the pH by separately using a pH adjusting agent.
  • the pH during the treatment is, for example, pH 7.0-9.0.
  • the treatment is conducted under a condition of pH 7.0 to pH 8.0. By adopting the condition, damaging of a material to be dyed associated with dyeing can be decreased.
  • the condition is specifically effective in dyeing human hairs, and it becomes possible to decrease the damage of the human hairs and the stimulation to the skin (scalp).
  • the material to be dyed is, in general, washed and finally dried.
  • water, a detergent or the like can be used for the washing.
  • air drying naturally drying
  • hot air drying spin drying
  • suction drying barrel drying and the like
  • the oxidation and polymerization of the oxidation dye are caused by the action of the modified enzyme, thereby the material to be dyed is dyed.
  • the damage of the material to be dyed associated with the dyeing treatment is little.
  • the possibilities for adverse effects (allergic response) on the scalp and the like are decreased in the case when the dyeing process is applied to the hairs.
  • the enzyme used in the present invention shows high affinity for the material to be dyed by the above-mentioned modification. By this characteristic, an enzymatic reaction (i.e., oxidation of the oxidation dye) effectively proceeds, and thus the dyeing effect is improved. Accordingly, the dyeing agent of the present invention enables effective dyeing while decreasing the influences on the material to be dyed and the like.
  • the modified enzyme in the present invention is also effective as a component for permanent wave agents.
  • the disulfide bonds (S-S) in the hairs are cut by an agent 1 comprising a reducing agent (thioglycolic acid, thioglycolates, cystein, hydroxycystein, dihydroxycystein, acetylated cystein, sodium sulfite and the like) as a main component, and the hairs are then treated by an agent 2 comprising an oxidizing agent as a main component to thereby reform the cut S-S bonds.
  • a reducing agent thioglycolic acid, thioglycolates, cystein, hydroxycystein, dihydroxycystein, acetylated cystein, sodium sulfite and the like
  • an agent 2 comprising an oxidizing agent as a main component to thereby reform the cut S-S bonds.
  • the oxidizing agent sodium bromate, perborate, hydrogen peroxide and the like are used.
  • the sample was purified by a 10DG column (BIO-RAD) that had been equilibrated with a 20 mM borate buffer solution (pH 9.0).
  • a reagent bilirubin was dissolved in 1.0 ml of a 0.05 mol/L phosphate buffer solution (pH 7.0) (containing 0.05 mmol/L EDTA) to give a substrate solution.
  • Sodium cholate was dissolved so as to become 1% in a 0.05 mol/L phosphate buffer solution (pH 7.0) (containing 0.05 mmol/L EDTA), and 3 ml of this was mixed with 0.2 ml of the substrate solution and 0.1 ml of the enzyme solution and then reacted at 37°C, and a measurement was conducted based on the decrease in the absorbance at 460 nm.
  • the amount of the enzyme required for oxidizing 1 ⁇ mol of bilirubin in 1 minute is defined as 1 unit.
  • the amino group was quantified by the following process.
  • the protein amounts in measurement samples were unified (within the range of protein amount: 0.6-1.0 mg/ml), and then the prepared sample (0.25 ml), 4% NaHCO 3 (0.25 ml) and an aqueous solution of 0.1% TNBS (0.25 ml) were mixed.
  • the mixture was reacted at 40°C for 2 hours.
  • the reaction was stopped by adding 5% SDS (0.25 ml) and 1M HCl (0.125 ml), and the absorbance at 345 nm was measured. Water was used as a blank instead of the measurement sample, and a value obtained by subtracting the measured value of the blank was used as ⁇ OD.
  • the binding amount of the amino group in the unmodified BO was defined as 8 (7 for lysine and 1 for N-terminal), and the amount of the amino group was quantified.
  • Fig. 1 The results of the isoelectric focusing are shown in Fig. 1 .
  • the untreated sample shows pI4, whereas the corresponding bands disappeared in all of the modified samples (it is considered that the electrical charge was improved). Furthermore, the band was smeared in all of the modified samples. The reason is considered that various BOs having different degrees of modification are present.
  • CM-700d manufactured by Konica Minolta, Inc.
  • a measurement was conducted under a visual field of 10°, D65 Day Light and an SCE mode.
  • CIEL*a*b Color System an evaluation was made based on the color difference from untreated white hairs ( ⁇ E*ab).
  • L* represents a luminosity value. The value ranges from 0 to 100, and a higher value shows higher luminance.
  • a* represents a color. The value ranges from -60 to +60, and the value closer to - represents stronger green and the the value closer to + represents stronger red.
  • b* represents a color.
  • ⁇ E*ab is a value calculated by [( ⁇ L) 2 +( ⁇ a) 2 +( ⁇ b) 2 ] 1/2 , and is a unit that is generally used in the evaluation of hair colors.
  • ⁇ E*ab is calculated by the difference of criteria values (the measured values of the white hairs before dyeing) from the values of L*, a* and b*. The relationship between the degree of the color difference and ⁇ E*ab is shown in Table 3.
  • ⁇ E*ab is about 40 in a general hair manicure, and ⁇ E*ab is 50 or more in a hair manicure using hydrogen peroxide as an oxidizing agent, but the values vary depending on the condition.
  • the results of the hair dye test 1 are shown in Table 4 and Fig. 2 .
  • the modified BO has a higher dyeing effect (difference of about 3 by color difference).
  • a difference in dyeing effect is observed also under the condition of pH 9.0.
  • the hairs are dyed in stronger red by the modified BO as a whole, and the values of a* (degree of redness) are higher (in the right of Fig. 2 ).
  • the impression by naked-eye observation was such that the hairs had been dyed better by the modified BO than the numerical values.
  • the results of the hair dye test 2 are shown in Table 5 and Fig. 3 .
  • the modified BOs have higher dyeing effects (the left of Fig. 3 ).
  • a tendency that the modified BO has a higher a* was shown in either pH (the right in Fig. 3 ).
  • the results of the hair dye test 3 are shown in Table 6 and Fig. 4 .
  • the modified BO showed a high dyeing effect even under a condition of a low enzyme concentration (the left of Fig. 4 ). Furthermore, it was confirmed that the modified BO had a higher degree of redness also in this test.
  • the dyeing effects were also examined for PAP (paraaminophenol) and PTD (paratoluenediamine) besides PPD (paraphenylenediamine) as chromogenic substrates (consideration of substrate specificity). Furthermore, an enzyme modified by using butylamine was newly prepared, and the dyeing effect thereof is similarly compared. The results are shown in Table 7 and Figs. 5 and 6 . It can be confirmed that the modified BO (putrescine) shows a high dyeing effect under a condition of pH 9.0 (the left of Fig. 5 ). Furthermore, the modified BO (putrescine) showed a tendency of a high degree of redness.
  • the BO modified with putrescine has a higher dyeing effect on PPD and PAP as compared to that of the unmodified BO ( Fig. 6 ). Furthermore, the BO modified with butylamine showed a tendency of a higher dyeing effect specifically on PTD ( Fig. 6 ).
  • the modified BO has a higher dyeing effect than that of the unmodified BO.
  • the difference in the dyeing effect was specifically significant at low enzyme concentrations.
  • the modified BO had stronger redness than that of the unmodified BO.
  • the pH of hairs is about 5.5, and hairs are negatively charged under a general dyeing condition (for example, pH 9.0).
  • the modified BO that has been positively (+) charged is present even under a condition of pH 9.0, as a result of the improved charge of the BO by the modification of the BO with an amino group.
  • the affinity for the hairs was improved by the effect of the charge in the modified BO, and consequently the dyeing effect was improved.
  • BO was modified by using various polyamines, and the dyeing effects were compared.
  • the sample was purified by a 10DG column (BIO-RAD) that had been equilibrated with a 20 mM borate buffer solution (pH 9.0).
  • a measurement method by the change in absorbance at a wavelength of 460 nm using bilirubin as a substrate was used.
  • the amino group was quantified by using TNBS.
  • the protein amount was quantified by the Bradford method. BSA was used as a standard.
  • a dyed hair bundle was immersed in a 10 vol% solution of EMAL 20C (Kao Corporation), and a sonication treatment was conducted for 30 minutes. Thereafter the hair bundle was washed thoroughly with water and dried, and the color difference was measured.
  • the shampoo resistance was represented by the color difference of the hairs after washing with respect to the color difference of the hairs before washing (%).
  • test method and evaluation were similar to those in the case of B, except that the above-mentioned PMO was used as the modified BO and an indole compound was used as the chromogenic substrate (in some conditions, two kinds of chromogenic substrates were used in combination). Furthermore, shampoo resistance tests were also conducted by a similar method to that in the case of C.
  • PMO was used as a modified enzyme.
  • Other process and the like were similar to those in the case of D.
  • Condition 1 4AI: 1% - PMO 0.25U/g 7 38.3 32.0 83.7
  • Condition 2 4AI: 1% - PMO 0.5U/g 7 40.7 40.0 98.2
  • Condition 3 4AI: 1% - PMO 1U/g 7 40.8 41.7 102.2
  • Condition 4 4AI: 1% - H 2 O 2 3% 9 19.1 18.0 94.3
  • Condition 5 4AI: 0.5% 5AI: 0.5% PMO 0.25U/g 7 37.2 32.4 87.1
  • Condition 6 4AI: 0.5% 5AI: 0.5% PMO 0.5U/g 7 39.5 31.2 79.1
  • Condition 7 0.5% 5AI: 0.5% PMO 1U/g 7 38.8 33.2 85.7
  • Condition 8 4AI: 0.5% 5AI:0.5% H 2 O 2 3% 9 23.4 24.2 103.3
  • Condition 9 4AI: 0.5% 6AI: 0.5% PMO 0.25U/g 7 38.9 24.2 62.2
  • Condition 10 4AI: 0.5% 4HI:0.5 % P
  • 5,6-Dihydroxyindole is a melanin precursor and polymerizes in the presence of oxygen to form a melanin pigment.
  • 5,6-dihydroxyindole is highly safe, the difficulty in handling and low dyeing effect thereof are considered to be problems.
  • test method and evaluation were conducted according to D. (Dyeing effects in cases when the indole analogues were used as chromogenic substrates 1), except that 0.3% by weight of 5,6-dihydroxyindole was used as a chromogenic substrate.
  • PMO is also effective in the case when 5,6-dihydroxyindole is used as a chromogenic substrate, in other words, effective dyeing is possible by using PMO.
  • the dyeing agent of the present invention is utilized for dyeing using oxidation dyes.
  • the dyeing agent of the present invention can be applied to various dyeing processes. Specifically, the present invention is effective for hair dyeing.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Textile Engineering (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring (AREA)
  • Tropical Medicine & Parasitology (AREA)
EP12782916.6A 2011-05-11 2012-05-10 Agent de coloration et son utilisation Not-in-force EP2708223B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011106532 2011-05-11
JP2011154209 2011-07-12
JP2011263158 2011-12-01
PCT/JP2012/061937 WO2012153791A1 (fr) 2011-05-11 2012-05-10 Agent de coloration et son utilisation

Publications (3)

Publication Number Publication Date
EP2708223A1 true EP2708223A1 (fr) 2014-03-19
EP2708223A4 EP2708223A4 (fr) 2014-11-12
EP2708223B1 EP2708223B1 (fr) 2017-02-01

Family

ID=47139266

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12782916.6A Not-in-force EP2708223B1 (fr) 2011-05-11 2012-05-10 Agent de coloration et son utilisation

Country Status (5)

Country Link
US (1) US8740994B2 (fr)
EP (1) EP2708223B1 (fr)
JP (2) JP5972262B2 (fr)
CN (1) CN103517703B (fr)
WO (1) WO2012153791A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8740994B2 (en) * 2011-05-11 2014-06-03 Amano Enzyme Inc. Dyeing agent and use for same
JP2013181023A (ja) * 2012-03-05 2013-09-12 Shisei Chemical Kk ケラチン繊維の染色方法及びケラチン繊維用染色剤
FR3047413B1 (fr) * 2016-02-04 2018-01-26 L'oreal Utilisation de composes polyamines a linker aliphatique en presence d’oxydants pour traiter les fibres keratiniques
CN109985608A (zh) * 2019-04-17 2019-07-09 辽宁石油化工大学 醋酸纤维素/聚乙烯亚胺-汽巴蓝f3ga膜及其制备方法和应用
CN112301008A (zh) * 2019-07-24 2021-02-02 中国医学科学院药物研究所 一种醛还原酶的氨基酸序列及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009909A1 (fr) * 1993-10-04 1995-04-13 Novo Nordisk A/S Preparation comportant une enzyme modifiee
US6152967A (en) * 1997-09-23 2000-11-28 L'oreal Oxidation dyeing composition for keratin fibres comprising bilirubin oxidase
US20040064901A1 (en) * 2000-11-20 2004-04-08 Astrid Kleen Enzymatic coloring agents
US20060021156A1 (en) * 1998-01-13 2006-02-02 L'oreal S.A. Composition for the oxidation dyeing of keratinous fibres containing a laccase and dyeing method using this composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59135886A (ja) 1983-01-25 1984-08-04 Takara Shuzo Co Ltd ビリルビン・オキシダ−ゼの製造法
JPH0653069B2 (ja) 1985-02-05 1994-07-20 旭化成工業株式会社 耐熱性ビリルビン・オキシダーゼの製造法
US4746606A (en) 1986-05-27 1988-05-24 Eastman Kodak Company Bilirubin-specific enzyme and its analytical use
JP2578430B2 (ja) 1987-06-10 1997-02-05 旭化成工業株式会社 新規なビリルビン．オキシダーゼおよびその製造法
JP2632518B2 (ja) 1987-08-28 1997-07-23 天野製薬株式会社 ビリルビンオキシダーゼの化学修飾体
JP3181660B2 (ja) 1992-01-24 2001-07-03 天野エンザイム株式会社 ビリルビンオキシダーゼの製造法
DE4406379A1 (de) 1993-03-24 1994-09-29 Boehringer Mannheim Gmbh Bilirubinoxidase aus Alfalfa und Verwendung des Enzyms
US6036729A (en) 1995-12-22 2000-03-14 Novo Nordisk A/S Enzymatic method for textile dyeing
US5972042A (en) 1995-12-22 1999-10-26 Novo Nordisk A/S Method for dyeing a material with a dyeing system which contains an enzymatic oxidizing agent
DE19617215A1 (de) * 1996-04-30 1997-11-06 Henkel Ecolab Gmbh & Co Ohg Kompaktreiniger für gewerbliche Geschirrspülmaschinen
AU737597B2 (en) * 1997-09-19 2001-08-23 Novozymes A/S Enzymatic foam compositions for dyeing keratinous fibres
FR2798854B1 (fr) 1999-09-24 2001-11-16 Oreal Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
JP2004089042A (ja) * 2002-08-30 2004-03-25 Amano Enzyme Inc 耐熱性ビリルビンオキシダーゼおよびその製造法
US7288120B2 (en) * 2003-12-12 2007-10-30 L'oreal S.A. Synthesis of tetraazapentamethine compounds, and processes for dyeing keratin fibers using this synthesis
JP2007112792A (ja) * 2005-09-21 2007-05-10 Kanazawa Univ ケラチン繊維染色用組成物及びケラチン繊維の染色方法
JP5211559B2 (ja) * 2006-12-07 2013-06-12 ソニー株式会社 熱安定性を有する変異型ビリルビンオキシダーゼ
JP2009044997A (ja) 2007-08-20 2009-03-05 Sony Corp ビリルビンオキシダーゼ（ｂｏｄ）の被覆方法
US8740994B2 (en) * 2011-05-11 2014-06-03 Amano Enzyme Inc. Dyeing agent and use for same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009909A1 (fr) * 1993-10-04 1995-04-13 Novo Nordisk A/S Preparation comportant une enzyme modifiee
US6152967A (en) * 1997-09-23 2000-11-28 L'oreal Oxidation dyeing composition for keratin fibres comprising bilirubin oxidase
US20060021156A1 (en) * 1998-01-13 2006-02-02 L'oreal S.A. Composition for the oxidation dyeing of keratinous fibres containing a laccase and dyeing method using this composition
US20040064901A1 (en) * 2000-11-20 2004-04-08 Astrid Kleen Enzymatic coloring agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012153791A1 *

Also Published As

Publication number Publication date
WO2012153791A1 (fr) 2012-11-15
JP2016166243A (ja) 2016-09-15
EP2708223A4 (fr) 2014-11-12
JP5972262B2 (ja) 2016-08-17
US8740994B2 (en) 2014-06-03
JPWO2012153791A1 (ja) 2014-07-31
CN103517703B (zh) 2016-11-09
EP2708223B1 (fr) 2017-02-01
JP6146884B2 (ja) 2017-06-14
CN103517703A (zh) 2014-01-15
US20140068875A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
JP6146884B2 (ja) 染色剤及びその用途
EP0504005B1 (fr) Composition pour la coloration enzymatique des fibres kératiniques, notamment des cheveux, et son application dans un procédé de coloration
EP0963192B1 (fr) Derives de l'acide diaminobenzoique en tant que precurseurs de matieres tinctoriales
EP0870082B1 (fr) Procede enzymatique de teinture
CN1216591C (zh) 用于染色角蛋白纤维的着色剂
JP2005532444A (ja) テトラアザペンタメチン化合物の直接染料としての使用および新規なテトラアザペンタメチン化合物
WO1997019998A1 (fr) Enzyme pour teindre des fibres keratiniques
EP2623093B1 (fr) Colorant pour fibres de kératine à l'aide de bilirubine oxydase et d'un derivative d'indole
US6409772B2 (en) Use of hydroxystilbenes for dyeing, ready-to-use composition containing them and dyeing process
US6001134A (en) Oxidation enzyme derived from a strain of the genus Pyricularia for the oxidative dyeing of keratinous fibers
CN1336168A (zh) 氧化组合物及用于染色,持久性整形或者漂白角蛋白纤维的用途
AU737597B2 (en) Enzymatic foam compositions for dyeing keratinous fibres
US7135184B2 (en) Culture having phenol oxidase-like activity
JP2007112792A (ja) ケラチン繊維染色用組成物及びケラチン繊維の染色方法
US20060021152A1 (en) Neutral phenol oxidase
CN106119218B (zh) 一种氧化酶及其应用
MXPA99004996A (en) Oxidation dyeing composition for keratin fibres and dyeing method using said composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20141013

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 9/04 20060101ALI20141128BHEP

Ipc: A61K 8/66 20060101AFI20141128BHEP

Ipc: D06P 1/32 20060101ALI20141128BHEP

Ipc: C12N 9/06 20060101ALI20141128BHEP

Ipc: A61Q 5/10 20060101ALI20141128BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160909

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 864959

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012028341

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170201

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 864959

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170601

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170502

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170501

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170531

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170601

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012028341

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

26N No opposition filed

Effective date: 20171103

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170531

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170510

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20170531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170510

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170510

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20180424

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170531

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20180411

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20120510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602012028341

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602012028341

Country of ref document: DE

Representative=s name: WITTHOFF JAEKEL STEINECKE PATENTANWAELTE PARTG, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170201